Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, when bashers are working hard, I consider it a buy-if signal, haha.
After CCTR and NUBL, NWMT's turn is coming? I bet $1000 on it, ha.
Come on, break it!
Shoot! TBIO sues PWRM! You win.
http://www.genomeweb.com/proteomics/transgenomic-sues-power3-libel-slander-breach-contract-protein-biomarker-deal
Transgenomic Sues Power3 for Libel, Slander, Breach of Contract in Protein Biomarker Deal
February 23, 2010
Type size:
-
+EmailPrinter-friendly versionRSS FeedView on one pageTransgenomic this week sued Power3 Medical Products, alleging breach of contract over a deal to market Power3's biomarker tests for neurodegenerative diseases.
The suit, filed in the US District Court in Nebraska, also accused Power3 of slander and libel, and of making "false representations" about its tests in order to "induce" Transgenomic into its marketing agreement with Power3.
Transgenomic said it has suffered more than $520,000 in damages. According to the company a press release issued by Power3 earlier this month terminating their contract and accusing Transgenomic of breach of contract and breach of confidentiality provisions caused Transgenomic's stock to fall 9 percent and lose more than $2 million of its market capitalization.
Transgenomic is asking the court to prohibit Power3 from continuing to defame it, as well as damages to be determined during trial, attorney's fees, and other expenses.
The lawsuit stems from an agreement Transgenomic and Power3 penned last year that gave Transgenomic exclusive rights to protein biomarkers from Power3, including those comprising its lead test NuroPro for Alzheimer's and Parkinson's diseases.
1 cent shortly.
Hope so, time to go back up!
love_the_pe...: Rampant optimism about a company without any definitive reason probably isn't the best reason to hold a stock.
If these diagnostic tests were so amazingly amazing, the merger would not be necessary nor would it be done at this time. Everything about this merger smells funny and when a pinksheet smells funny, you have to protect your investment and move it into something more stable.
Good luck to you guys. I'm going to be watching it all from the sidelines.
From Yahoo!
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_P/threadview?m=te&bn=73718&tid=26223&mid=-1&tof=1&rt=2&frt=2&off=1#-1
I'm wondering too, is Hubai the new name after the 4-way merge? Sound like not a mistake.
I'm out, GLTA!
IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this Agreement to be signed by their respective officers hereunto duly authorized, all as of the date first written above.
POWER3 MEDICAL PRODUCTS, INC.
By: /s/ Ira L. Goldknopf
Ira L. Goldknopf
President and Chief Scientific Officer
POWER3 ACQUISITION CORP.
By: /s/ Ira L. Goldknopf
Ira L. Goldknopf
President and Chief Scientific Officer
STEMTRONIX, INC.
By: /s/ Helen R. Park
Helen R. Park
President and Chief Financial Officer
This company leaks news constantly always leaving me behind! Do they have to tell news to anybody calls them?
What's behind the news?!! Shoot!
Think it over again, Blox, not just wishful thoughts. I wish I only bet what I can lose on it but I always bet more, haha.
If 93.5 % was the P2 result and it had leaked out, the pps won't be like this.
If the products are so good, why TBIO did not make a single sale in 12 months? Just to throw 220K USD away? If PWRM is really huge, do you think TBIO will let it go like that?
Chinese partner and China market, yes, nice dream! With good P2 results, not only a Chinese partner, I see partners from all over the planet!
If it's a long wait for P2 results, PWRM will go up and down a lot. If you are really long, you don't have to pump it here and there, because you might trick new comers into a violent ride and get names.
Anyways, I hold a half and trade a half having fun watching it go. Go, PWRM!
PR coming? Go, PWRM!
We need more news! Override the last one asap!
Percent of global Internet users who visit power3medical.com:
Reach Change
Yesterday - - We do not have enough data to display this metric for this site.
7 day - - We do not have enough data to display this metric for this site.
1 month 0.00033 +130%
3 month 0.00022 +430%
PWRM - Power 3 Medical Prod (OTCBB)
Date Open High Low Last Change Volume % Change
02/05/10 0.1040 0.1050 0.0950 0.1000 -0.0039 1669200 -3.75%
Composite Indicator
Trend Spotter TM Sell
Short Term Indicators
7 Day Average Directional Indicator Sell
10 - 8 Day Moving Average Hilo Channel Sell
20 Day Moving Average vs Price Sell
20 - 50 Day MACD Oscillator Hold
20 Day Bollinger Bands Hold
Short Term Indicators Average: 60% - Sell
20-Day Average Volume - 1972510
Medium Term Indicators
40 Day Commodity Channel Index Sell
50 Day Moving Average vs Price Sell
20 - 100 Day MACD Oscillator Buy
50 Day Parabolic Time/Price Sell
Medium Term Indicators Average: 50% - Sell
50-Day Average Volume - 2385860
Long Term Indicators
60 Day Commodity Channel Index Hold
100 Day Moving Average vs Price Sell
50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: - Hold
100-Day Average Volume - 3644028
Overall Average: 48% - Sell
Price Support Pivot Point Resistance
0.1000 0.0900 0.1000 0.1100
POWER 3 MEDICAL PRODUCTS INC
Daily Commentary
BUY-IF
0.1000
-0.0039 -3.75%
Candlestick Analysis
Today’s Candlestick Patterns:
Black Spinning Top
Our system posted a BUY-IF today. The previous SELL recommendation was issued on 01.29.2010 (7) days ago, when the stock price was 0.1212. Since then PWRM has fallen -17.49% .
The BUY-IF alert is still valid. A confirmation today however is denied. The pattern is not rejected yet since the day was not a long black candlestick one. The market is currently testing your patience. Continue to do your homework by digesting all available information around.
The final judgment about the evolving pattern waits the next session. Either the alert will be confirmed by one of the valid confirmation criteria or the bullish alert will be void and null.
I've sold some on the bounce and will buy it back on a real uptrend. I just don't understand the fact of zero sales in 12 months with 220K royalty, Transgenomic must be stupid or something is not known to me. Better safe than sorry, I had a 100% position on PWRM.
Watching with my ticket...
It's easy to hire some 18 year old girl to work for you but where can you find 80 years of experence, man.
Go, PWRM!
If MMs wanted to lower pps with news and get more shares yesterday, it may take days for the greedy MMs to feel full. Let's watch.
Apparently the timing is suspicious! The news helped to break the .10 support. Bad people!
If below is true, you might get your order filled but hopefully you'll cancel the order.
Re: My take on today's news 3-Feb-10 05:00 pm Totally agree. I actually posted the same thought a couple hours back. In addition, I spoke with Ken from IR this morning before press releases came out and he indicated one was to come out this week (todays I assume) but he also indicated that a more pertinant info to be released by end of quarter but likelihood of nothing major happening till summer. Anyone who doubts just give him a call Rating :
(1 Rating)Rate it: jburke22_ki...
Male
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_P/threadview?m=te&bn=73718&tid=21940&mid=21940&tof=15&frt=2#21940
Then we want it now!
The termination of the Collaboration and Exclusive License Agreement! WTH, no sales in 12 months?!
Section 1 – Registrant’s Business and Operations
Item 1.02 Termination of a Material Definitive Agreement.
On February 2, 2010, Power3 Medical Products, Inc. (the “Company”) delivered notice of termination of the Collaboration and Exclusive License Agreement (the “Agreement”), dated January 23, 2009, between the Company and Transgenomic, Inc. (“Transgenomic”), to Transgenomic.
Under the Agreement, the Company granted an exclusive, royalty-bearing license to Transgenomic to develop certain patent rights and other proprietary information of the Company and sell products that use the patent rights and other proprietary information. The Company had the right to terminate the Agreement in the event Transgenomic failed to complete the first commercial sale of a licensed product within 12 months of the date the Agreement was executed, and had the right to terminate the Agreement in the event Transgenomic committed one or more material breaches of the Agreement. Transgenomic failed to complete the first commercial sale of a licensed product within 12 months of the date the Agreement was executed. In addition, Transgenomic committed material breaches of the Agreement, including a breach of the confidentiality provisions of the Agreement. As a result, on February 2, 2010, the Company exercised its right to terminate the Agreement for the aforementioned reasons.
The termination of the Agreement becomes effective 90 days after the date the notice of termination was received by Transgenomic in connection with its failure to complete the first commercial sale of a licensed product within 12 months of the date the Agreement was executed, and becomes effective 45 days after the date the notice of termination was received by Transgenomic in connection with the material breaches of the Agreement that were committed by Transgenomic, including its breach of the confidentiality provisions of the Agreement.
The Company did not incur any early termination penalties in connection with its decision to terminate the Agreement.
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
POWER3 MEDICAL PRODUCTS, INC.
Dated: February 3, 2010 /s/ Helen R. Park
Helen R. Park
Chief Executive Officer
Dilution is not a problem, penny stocks do it all the time, but how big? Is it the 30M$ coming? I'm in panic mode, sell or trasfer more fund? Thinking hard!!
Good huge or bad huge? Shooooot!
Highly possible, timing is the key, ha.
Go, PWRM!
Biotech Stock Alert for Power 3 Medical Products Inc. Issued by Beacon Equity
http://www.tradingmarkets.com/news/stock-alert/pwrm_pwrm_biotech-stock-alert-for-power-3-medical-products-inc-issued-by-beacon-equity-745034.html
Power 3 Medical Products Inc. (PWRM) is a development-stage biotechnology company specializing in the early detection of breast cancer, Alzheimer's disease, Lou Gehrig's disease, Parkinson's disease, leukemia, gastrointestinal disease and metabolic syndrome. The Company focuses upon the study of proteomics, which identifies 334 protein biomarkers for the above-named diseases.
In the report, the analyst notes:
"The Company presently operates at a deficit, with minimal operating revenues from the sale of its products and services at this time. Management is pursuing third-party licensing, collaboration and distribution agreements to generate revenue from its disease diagnosis biomarker and drug resistance identification systems. The Company's proprietary identification system aids in the areas of various cancers, neurodegenerative and neuromuscular diseases.
"The Company's goal is to complete phase II of its testing to identify Alzheimer's and Parkinson's disease. Partnering with Transgenomic Inc., the Company expects to complete phase II and begin to commercialize its testing products during the first quarter of 2010.
"The Company stated in its latest 10-Q of November 16, that it seeks grants and other sources of funding to take its BC-SeraPro(TM) and NuroPro Blood Test to full commercialization and to continue operations."
To read the entire report visit: http://www.beaconequity.com/i/PWRM
Hope you are right we fly a little bit but the wait might be not just a few days, maybe weeks or months before we fly to the moon!
Supper funny today! 100 shares (20 bucks) can drive the price 6% any direction, ha!
Control the pace before the lift off. Go, PWRM!
Happy holding, lazordude!
http://www.alexa.com/siteinfo/power3medical.com#
funny:
Top Keywords from Search Traffic
The top keywords driving traffic to power3medical.com from search engines. Updated monthly.
Keyword
Percent of Search Traffic
1
power3
24.95%
2
power 3
21.09%
3
power3 medical
7.03%
4
power3 t
5.38%
5
power 3 medical
5.07%
6
power -3
3.84%
7
the power 3
3.54%
8
power of 3
3.47%
9
pwrm.ob
2.99%
10
2*pi*4.5*10^-5
2.84%
It looks just a little power can drive this thing up or down easily, ha.
0.128 0.0050 4.07% 14,000 Last Trade as of 9:31 AM ET 1/28/10 Last Change / % Change Volume
Anthony1983: I don't have the link right now, oh, I found it.
http://www.alexa.com/siteinfo/power3medical.com
7 day 0.00038 +310%
1 month 0.00028 +30%
3 month 0.00018 +400%
Volume will go up, hold on. A lot of people are checking out P3.
Percent of global Internet users who visit power3medical.com:
Reach Change
7 day 0.00037 +290%
1 month 0.00026 +20%
3 month 0.00018 +410%
Go, PWRM!
OK, patience, but I don't have much of it. Instead I can try to stop watching it and check it once a while. I'll try watch news but not pps for a while. Go, PWRM. Good luck to all!
money.cnn.com: Drug Discovery Conference PR, why the PR has a lot of â€Â? Shoot!
HOUSTON, Jan. 20, 2010 (GLOBE NEWSWIRE) -- Power3 Medical Products, Inc. (OTCBB:PWRM) is pleased to announce that the company will be a sponsor and have an exhibit booth at the 4th Annual Conference of the Alzheimer's Drug Discovery Foundation on Drug Discovery for Neurodegeneration in Houston on February 1-2, 2010.
“This meeting is particularly appropriate for the company. The NuroPro® blood protein biomarkers and tests for early detection, differential diagnosis, and monitoring of therapeutic response of Alzheimer’s disease, Parkinson’s disease and ALS are progressing through clinical validation trials,†said Dr. Ira L. Goldknopf, Chief Scientific Officer. “Power3 remains at the forefront of this area.â€Â
 “I am proud of the continued progress of Power3 in the neurodegenerative diseases. We are continuing publication and promotion of the exciting results of our clinical validation trials in these areas and are glad to have the opportunity to move into the marketing area of drug discovery,†said Helen R. Park, CEO of Power3 Medical. “We are eager to make an impact in drug discovery for neurodegenerative disease and think our presence at this conference will provide inroads into that area.â€
http://money.cnn.com/news/newsfeeds/articles/globenewswire/182288.htm
PD Patent application title: Complement factor H protein as a biomarker of Parkinson's disease
Inventors: Ira L. Goldknopf Essam A. Sheta Jennifer K. Bryson
Agents: Benjamin A. Adler, PhD, JD
Assignees:
Origin: HOUSTON, TX US
IPC8 Class: AG01N3353FI
USPC Class: 435 71
Patent application number: 20090275046
Read more: http://www.faqs.org/patents/app/20090275046
Patent application title: Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer
Inventors: Ira L. Goldknopf
Agents: Benjamin A. Adler, PhD, JD
Assignees: Power3 Medical Products, Inc.
Origin: HOUSTON, TX US
IPC8 Class: AG06F1900FI
USPC Class: 702 19
Patent application number: 20100004871
Read more: http://www.faqs.org/patents/app/20100004871
Nice picture, HossPepper! My problem is that I've bet my a$$ on PWRM and it's sliding when we are waiting for good news and I don't know how much more I can take. Last year I bought it above 8 cents and sold all at 5 cents, then chased in at 7.5. I'm afraid that I'll repeat my error again.
Go, PWRM!
Update of Power3 on their home page but now new stuff: http://www.power3medical.com/default.aspx
In November of 2009, Dr. Goldknopf was the Keynote speaker and Session Chair of the session entitled “Biomarkers and Diagnostics in Personalized Medicine” at the BIT International Congress and Exposition of Molecular Diagnostics (ICEMD 2009) meeting in Beijing, China.
Presently, through our collaboration with Transgenomic, Inc. the company is preparing to commercialize the Alzheimer’s disease diagnostic test and the Parkinson’s disease diagnostic test in Transgenomic’s CLIA certified lab in the first quarter of 2010, from which Power3 will receive milestone payments and Royalties. Power3 in 2009 had revenues of over $200,000 which included the license fee and operations support from Transgenomic, Inc.
The management of Power3 Medical Products, Inc. wishes to thank the many shareholders, investors and vendors who stepped up to the plate to provide Power3 the means to continue its mission to provide the world with new and better tools for the understanding and diagnostics of diseases to fulfill critical unmet needs. The management has worked exceedingly hard to sustain our progress during this economic down turn. We will continue to serve to the best of our ability for the science, the future of the company, and the shareholders. We feel blessed to be in this industry.
Helen R. Park, M.S.
Power3 Medical Products, Inc. CEO
FDA approval is not required but may drive pps way higher if we get one.
http://www.gekkowire.com/?p=2230
"while it may be true that the company can market the device without FDA approval, garnering approval would be greatly within the company’s interests."
My Scottrade online order for today:
Limit Order Placed
Thank you! Your order to Buy 30000 Shares of PWRM (POWER3 MEDICAL PRODUCTS INC) at Limit Price of $0.131 has been submitted. Duration of order is Today (Good until 4:00 PM ET).
Order Confirmation #: XPDEC9720100120
Order Time: 1/20/2010 9:38 AM ET
Any order entered after market close is good for the next business day.
Check Order Status Place Another Trade
It's going up and down while we're waiting and it'll be a long wait. We expect a lot of good news for PWRM and hope it worth the wait.
Going strong, go, pwrm!